Send me a link:

*Text messaging rates may apply.

 Dow Down0.72% Nasdaq Down0.50%

More On ELX.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Ellex Medical Lasers Limited (ELX.AX)

-ASX
0.36 0.00(0.00%) Jul 24, 8:15PM EDT
ProfileGet Profile for:
Ellex Medical Lasers Limited
82 Gilbert Street
Adelaide, SA 5000
Australia - Map
Phone: 61 8 8104 5200
Fax: 61 8 8104 5231
Website: http://www.ellex.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Appliances & Equipment
Full Time Employees:201

Business Summary 

Ellex Medical Lasers Limited designs, manufactures, markets, and sells lasers and diagnostic ultrasound systems for ophthalmologists to diagnose and treat eye diseases. The company offers Photodisruptors under the Ultra Q and Super Q names for the treatment of secondary cataracts; Photocoagulators under the Integre Duo, Integre, Solitaire, Integre Pro, and Integre Yellow names to treat age-related macular degeneration (AMD) and diabetic retinal diseases; and Selective Laser Trabeculoplasty Photoregeneration systems under the Tango and Solo names for the treatment of glaucoma, as well as Diagnostic Ultrasound Systems under the Eye Cubed name to visualize anatomy and structures below the surface of the retina. It also develops Ellex Retinal Rejuvenation Therapy, a laser therapy that is in clinical trials for the treatment of AMD and diabetic retinopathy. The company sells its products directly to end-user customers, as well as through independent third-party distributors in Australia, the United States, Europe, the Middle East, Asia, South America, and internationally. Ellex Medical Lasers Limited is based in Adelaide, Australia.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Ellex Medical Lasers Limited

Key Executives 
 PayExercised
Mr. Victor Previn BE, 56
Founder, Exec. Chairman, Technical Director, Member of Audit Committee and Member of Remuneration Committee
55.00KN/A
Mr. Thomas H. Spurling BSc (Hons), Ph.D., FRACI FTSE, AM,
Group Chief Exec. Officer
340.00KN/A
Mr. Malcolm Plunkett , 60
VP of Adavnced Research
204.00KN/A
Ms. Maria Maieli ,
Group Financial Controller and Company Sec.
N/AN/A
Mr. Richard Stone ,
VP Operations & Engineering
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in AUD.